Subscribe to RSS - insulin pumps

insulin pumps

DMS looks beyond strips


NEW ORLEANS –With the national mail-order program for diabetes testing supplies drastically changing the marketplace, provider Cynthia Pazos made a deliberate shift toward insulin pumps and other advanced diabetes therapies in 2016—and hasn’t looked back.

PE firm seeks to leverage technology in diabetes market


LOS ANGELES – With its recent acquisition of Mini Pharmacy, Angeles Equity Partners has a platform to serve a growing diabetes population, says a spokesman for the private equity firm.

Tandem targets Australasia


SAN DIEGO – Medical Device maker Tandem Diabetes Care has inked distribution agreements with Australasian Medical & Scientific Ltd (AMSL) and New Zealand Medical & Scientific Ltd (NZMS) to distribute Tandem’s t:slim X2 Insulin Pump in Australia and New Zealand, re

Insulet: ‘We are well on our way’


BILLERICA, Mass. – Insulet Corp. reported revenue of $130.5 million for the fourth quarter of 2017, an increase of 26% compared to the same period in 2016. U.S. revenue from the Omnipod was $76.5 million, an increase of 21%. Full-year revenue was $463.8 million and U.S.

Insulin pump decision could have chilling effect

By Theresa Flaherty, Managing Editor

YARMOUTH, Maine – UnitedHealthcare’s recent decision to only cover insulin pumps provided by Medtronic is bad news all around, say industry stakeholders.

Study outlines access issues for insulin pumps


CHICAGO – A recent survey by the American Association of Diabetes Educators found that beneficiary access to insulin pumps and supplies in Round 1 bid areas is “a little worse than expected.”

Study finds access issues for insulin pumps


CHICAGO – Contract suppliers aren’t making insulin pumps and replacement supplies available to Medicare beneficiaries in competitive bidding areas, says the American Association of Diabetes Educators.

Revenues climb at Insulet


BEDFORD, Mass. – Insulet, a provider of insulin pumps for patients with diabetes, reported $58.7 million in revenues for the fourth quarter of 2012, a 23% increase over the same period in 2011. It reported net losses of $10.2 million vs. $14.3 million.

NHIA won't give up

The association says questions about patient safety have not been addressed by CMS officials

ALEXANDRIA, Va. – The latest attempt by stakeholders to get CMS to rethink its decision to include home infusion in the Round 1 recompete didn’t get very far.

AAHomecare: Separate insulin, external infusion pumps


BALTIMORE – CMS appears committed to including home infusion in the Round 1 re-compete, but that hasn't stopped stakeholders from trying to persuade the agency to do otherwise.